Cigna Corp (CI)

Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company

This actively managed value fund has outperformed the S&P 500 and Nasdaq-100 in the past year.

Check out the companies making headlines yesterday: RXO (NYSE:RXO): Freight Delivery Company RXO (NYSE:RXO) rose by 4.2% on Monday after Stifel raised its pr...

What Happened? Shares of health insurance company Cigna (NYSE:CI) jumped 3.5% in the afternoon session after analyst firm Bernstein raised its price target o...

Nearly 5,000 independent pharmacies sue Prime Therapeutics for antitrust violations & price-fixing with Cigna's Express Scripts.

Strong productivity gains from AI -- and lower inflation -- could be good news for these Vanguard ETFs.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...

Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers....

Over the past six months, Molina Healthcare has been a great trade, beating the S&P 500 by 10.8%. Its stock price has climbed to $200, representing a healthy...

Cigna trades at $298.08 and has moved in lockstep with the market. Its shares have returned 7.6% over the last six months while the S&P 500 has gained 8.4%. ...

Eli Lilly emerged as the "clear winner" from the ADA meeting last weekend in New Orleans, an analyst said following the event.

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy benefit manager CVS Health.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Top Wall Street analysts changed outlook on top names. For all changes, see analyst ratings page. Analysts have mixed views on CI stock.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...

Cigna has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Heartflow and Neptune Insurance deserve a closer look.

Cigna’s first quarter results reflected momentum in its core health services and specialty pharmacy businesses, as management highlighted strong demand for s...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

What Happened? Shares of health insurance company Cigna (NYSE:CI) fell 2.5% in the afternoon session after the company announced it will exit the Affordable ...

Cigna Group (CI) Q1 2026 Earnings Call Transcript